A comparison of aspiration, antazoline sclerotherapy and surgery in the treatment of hydrocele.
Of 98 hydroceles (mean volume 125 ml) in a consecutive series of 92 patients, treated initially by aspiration, 14% (mean volume 70 ml) were cured. The 76 recurring hydroceles (mean volume 146 ml) were then randomised to either antazoline sclerotherapy on an out-patient basis or surgery. Cure rates were 89 and 100%, respectively, at follow-up 6 months later. Operated patients were admitted for a mean duration of 2.5 days. The results indicated that aspiration alone was inadequate, and sclerotherapy is advocated as the first choice of treatment for hydrocele.
Roosen
J U
JU
Department of Surgery, Frederikssund Sygehus, Denmark.
Larsen
T
T
Iversen
E
E
Berg
J B
JB
D000328:Adult; D000368:Aged; D000865:Antazoline / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D012008:Recurrence; D012597:Sclerosing Solutions / Q000627:therapeutic use; D015911:Sclerotherapy; D013396:Suction; D006848:Testicular Hydrocele / Q000601:surgery* / Q000628:therapy*
D012597:Sclerosing Solutions; D000865:Antazoline